国邦医药
(605507)
| 流通市值：122.91亿 | | | 总市值：122.91亿 |
| 流通股本：7.82亿 | | | 总股本：7.82亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 4,588,833,002.88 | 3,142,428,542.07 | 1,520,880,277.95 | 6,011,397,499.1 |
| 营业总成本 | 4,070,056,629.18 | 2,771,333,618.87 | 1,334,911,518.48 | 5,101,191,544.3 |
| 其他经营收益 | | | | |
| 营业利润 | 538,383,906.46 | 390,710,305.92 | 187,940,079.79 | 963,993,951.63 |
| 利润总额 | 534,193,797.22 | 387,837,408.67 | 187,173,418.77 | 951,259,911.75 |
| 净利润 | 471,628,404.39 | 341,322,474.13 | 160,128,633.56 | 817,573,712.5 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 471,628,404.39 | 341,322,474.13 | 160,128,633.56 | 817,573,712.5 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 6,224,371,212.6 | 6,470,751,666.11 | 6,531,692,348.03 | 6,112,848,808.72 |
| 非流动资产: | | | | |
| 非流动资产合计 | 5,037,980,977.43 | 4,912,567,707.74 | 4,864,102,587.55 | 4,871,786,859.23 |
| 资产总计 | 11,262,352,190.03 | 11,383,319,373.85 | 11,395,794,935.58 | 10,984,635,667.95 |
| 流动负债: | | | | |
| 流动负债合计 | 2,545,081,689.71 | 2,774,807,004.43 | 2,571,091,409.77 | 1,921,262,333.75 |
| 非流动负债: | | | | |
| 非流动负债合计 | 200,513,491.92 | 206,833,793.22 | 109,018,372.18 | 507,816,814.13 |
| 负债合计 | 2,745,595,181.63 | 2,981,640,797.65 | 2,680,109,781.95 | 2,429,079,147.88 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 8,514,057,887.05 | 8,399,271,382.99 | 8,713,753,411.68 | 8,553,123,737 |
| 股东权益合计 | 8,516,757,008.4 | 8,401,678,576.2 | 8,715,685,153.63 | 8,555,556,520.07 |
| 负债和股东权益合计 | 11,262,352,190.03 | 11,383,319,373.85 | 11,395,794,935.58 | 10,984,635,667.95 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 4,008,935,489.36 | 2,686,365,864 | 1,144,813,298.98 | 4,780,269,295.43 |
| 经营活动现金流出小计 | 3,250,406,624.02 | 2,231,416,330.29 | 951,636,776.9 | 4,220,991,135.85 |
| 经营活动产生的现金流量净额 | 758,528,865.34 | 454,949,533.71 | 193,176,522.08 | 559,278,159.58 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 8,683,974,144.09 | 6,552,703,272.86 | 3,383,229,932.46 | 15,392,841,002.9 |
| 投资活动现金流出小计 | 9,157,279,741.43 | 6,703,419,647.11 | 3,476,488,235.6 | 16,244,299,904.44 |
| 投资活动产生的现金流量净额 | -473,305,597.34 | -150,716,374.25 | -93,258,303.14 | -851,458,901.54 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 485,000,000 | 485,000,000 | 325,000,000 | 1,216,605,958.45 |
| 筹资活动现金流出小计 | 992,695,822.34 | 905,214,087.28 | 278,906,260.44 | 1,339,553,954.51 |
| 筹资活动产生的现金流量净额 | -507,695,822.34 | -420,214,087.28 | 46,093,739.56 | -122,947,996.06 |
| 汇率变动对现金及现金等价物的影响 | -27,387,258.03 | -18,995,565.99 | -7,741,059.84 | -1,358,562.08 |
| 现金及现金等价物净增加额 | -249,859,812.37 | -134,976,493.81 | 138,270,898.66 | -416,487,300.1 |
| 期末现金及现金等价物余额 | 868,024,451.37 | 982,907,769.93 | 1,256,155,162.4 | 1,117,884,263.74 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -134,976,493.81 | - | -416,487,300.1 |
最新报告期：2026-10-26| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 开源证券 | 阮帅,余汝意 | 0.98 | 1.44 | 1.87 | 2026-10-26 |
| 天风证券 | 杨松 | 1.07 | 1.43 | 1.62 | 2026-10-11 |
| 浙商证券 | 盖文化,郭双喜 | 1.08 | 1.31 | 1.55 | 2026-09-07 |
| 招商证券 | 侯彪,梁广楷,许菲菲 | 1.22 | 1.61 | 1.86 | 2026-08-25 |